Stock Scorecard
Stock Summary for Conmed Corp (CNMD) - $44.03 as of 12/3/2025 3:44:27 PM EST
Total Score
15 out of 30
Safety Score
47 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for CNMD
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CNMD
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CNMD
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for CNMD
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for CNMD (47 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 1 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 4 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 7 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for CNMD
Financial Details for CNMD
Company Overview |
|
|---|---|
| Ticker | CNMD |
| Company Name | Conmed Corp |
| Country | USA |
| Description | CONMED Corporation (CNMD) is a prominent medical technology firm based in Largo, Florida, specializing in innovative minimally invasive surgical devices and equipment aimed at enhancing surgical performance and patient outcomes. The company provides a comprehensive array of solutions across various medical fields, including orthopedics, general surgery, and gynecology, underscoring its versatility and commitment to healthcare excellence. With a strong emphasis on quality and reliability, CONMED serves as a crucial partner for healthcare professionals, significantly contributing to improved surgical safety and efficiency while solidifying its competitive presence in the global healthcare landscape. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 1/29/2026 |
Stock Price History |
|
| Last Day Price | 44.03 |
| Price 4 Years Ago | 136.58 |
| Last Day Price Updated | 12/3/2025 3:44:27 PM EST |
| Last Day Volume | 401,685 |
| Average Daily Volume | 504,795 |
| 52-Week High | 75.30 |
| 52-Week Low | 40.16 |
| Last Price to 52 Week Low | 9.64% |
Valuation Measures |
|
| Trailing PE | 21.48 |
| Industry PE | 45.50 |
| Sector PE | 88.06 |
| 5-Year Average PE | 27.93 |
| Free Cash Flow Ratio | 34.94 |
| Industry Free Cash Flow Ratio | 27.49 |
| Sector Free Cash Flow Ratio | 28.78 |
| Current Ratio Most Recent Quarter | 2.10 |
| Total Cash Per Share | 1.26 |
| Book Value Per Share Most Recent Quarter | 32.57 |
| Price to Book Ratio | 1.37 |
| Industry Price to Book Ratio | 4.38 |
| Sector Price to Book Ratio | 33.12 |
| Price to Sales Ratio Twelve Trailing Months | 1.01 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.92 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.97 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 30,968,000 |
| Market Capitalization | 1,363,521,040 |
| Institutional Ownership | 114.21% |
Dividends |
|
| Ex-Dividend Date | 9/15/2025 |
| Previous Dividend Amount | 0.2000 |
| Current Dividend Amount | 0.2000 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.80 |
| Trailing Annual Dividend Yield | 1.84% |
| Forward Annual Dividend Rate | 0.80 |
| Forward Annual Dividend Yield | 1.84% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 1.49% |
| 5-Year Average Dividend Yield | 1.05% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 2.43% |
| Dividend Payout Ratio | 39.02% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -94.30% |
| Annual Earnings Growth | 105.44% |
| Reported EPS 12 Trailing Months | 2.05 |
| Reported EPS Past Year | 2.72 |
| Reported EPS Prior Year | 4.16 |
| Net Income Twelve Trailing Months | 64,071,000 |
| Net Income Past Year | 132,423,000 |
| Net Income Prior Year | 64,459,000 |
| Quarterly Revenue Growth YOY | 6.70% |
| 5-Year Revenue Growth | 6.47% |
| Operating Margin Twelve Trailing Months | 10.80% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 38,929,000 |
| Total Cash Past Year | 24,459,000 |
| Total Cash Prior Year | 24,296,000 |
| Net Cash Position Most Recent Quarter | -814,078,000 |
| Net Cash Position Past Year | -880,607,000 |
| Long Term Debt Past Year | 905,066,000 |
| Long Term Debt Prior Year | 973,140,000 |
| Total Debt Most Recent Quarter | 853,007,000 |
| Equity to Debt Ratio Past Year | 0.52 |
| Equity to Debt Ratio Most Recent Quarter | 0.54 |
| Total Stockholder Equity Past Year | 962,681,000 |
| Total Stockholder Equity Prior Year | 834,222,000 |
| Total Stockholder Equity Most Recent Quarter | 1,008,263,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 148,957,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 4.81 |
| Free Cash Flow Past Year | 153,884,000 |
| Free Cash Flow Prior Year | 106,316,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.87 |
| MACD Signal | -1.13 |
| 20-Day Bollinger Lower Band | 39.20 |
| 20-Day Bollinger Middle Band | 48.40 |
| 20-Day Bollinger Upper Band | 57.59 |
| Beta | 0.98 |
| RSI | 46.84 |
| 50-Day SMA | 54.80 |
| 150-Day SMA | 78.68 |
| 200-Day SMA | 84.58 |
System |
|
| Modified | 12/3/2025 8:38:03 PM EST |